Conditions: Sexual Dysfunctions, Psychological Depression
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 111
Healthy volunteers: no

Brief summary:
The current trial will explore the safety of flibanserin in combination with Selective Serotonin Reuptake Inhibitors or Norepinephrine Serotonin Reuptake Inhibitors in a representative population of women with depressive and possible concurrent anxiety symptomatology.

Detailed description:

Arms:
arm 1: Patient to receive one tablet of flibanserin 50 mg and one tablet of flibanserin placebo qhs for 14 days then will receive 2 flibanserin tablets of 50 mg qhs arm 2: Patient to receive 2 flibanserin tablets of 50 mg qhs arm 3: Patient to receive 2 placebo tablets of 50 mg qhs

Interventions: intervention 1: flibanserin 50 mg to 100 mg qhs intervention 2: flibanserin 100 mg qhs intervention 3: placebo 2 tablets qhs
Intervention descriptions: intervention 1: 50 to 100mg qhs intervention 2: 100mg qhs intervention 3: 50 mg placebo

Protocol document: